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Background: Autism spectrum disorder (ASD) is often associated with epilepsy.
Previous studies have also shown increased rates of electroencephalographic (EEG)
alteration in ASD patients without epilepsy. The aim of this study was to compare
the rate of intermittent rhythmic delta and theta activity (IRDA/IRTA) events between
high-functioning adult patients with ASD and matched healthy controls.
Materials and Methods: Routine EEG records of 19 ASD patients and 19 matched
controls were screened for IRDA/IRTA using a fully data driven analysis with fixed
thresholds. IRDA/IRTA rates before and after hyperventilation (HV) as well as the
HV-induced difference in IRDA/IRTA rates (HV difference) were analyzed. For inter-group
measures, we used the Wilcoxon rank sum test.
Results: Significantly increased HV difference was detected in the ASD group
(p = 0.0497). However, the groups showed no difference in IRDA/IRTA rates before
HV (p = 0.564) and after HV (p = 0.163).
Conclusions: The lack of any group differences regarding IRDA/IRTA before HV might
be related to the fact that we only studied non-secondary high-functioning autism in
a small sample of epilepsy-free adult patients. A significantly increased HV difference
might be regarded as a marker of subtle neuronal network instability possibly causing
short-term disturbances via local area network inhibition and long-term effects via
epileptic encephalopathy.
Keywords: Asperger syndrome, autism spectrum disorder, EEG, adults, IRDA
Abbreviations: ADHD, attention deficit hyperactivity disorder; AQ, autism spectrum quotient; ASD, autism spectrum
disorder; cMRI, cerebral magnetic resonance imaging; EEG, electroencephalography; EOG, electrooculography; EQ, empathy
quotient; ICA, independent component analysis; IQ, intelligence quotient; IRDA, intermittent rhythmic delta activity;
IRTA, intermittent rhythmic theta activity; HV, hyperventilation; MWT-B, multiple-choice vocabulary intelligence test;
WURS, Wender Utah Rating Scale.
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BACKGROUND
High-functioning autism spectrum disorder (ASD) is a
common neurodevelopmental and basic psychiatric disorder
(Tebartz van Elst, 2013; Tebartz van Elst et al., 2013). Its
prevalence varies between 1% and 2.7%, with increased
rates in men (Brugha et al., 2011; Kim et al., 2011). ASD is
characterized by long-lasting deficits in social communication,
repetitive/stereotypical behavior, and special interests (Tebartz
van Elst, 2013; Tebartz van Elst et al., 2013; Lai et al., 2014).
Patients with high-functioning forms of ASD have normal
or above-average intelligence quotients (IQs) and are able to
use language on a superficial level (Tebartz van Elst, 2013;
Tebartz van Elst et al., 2013). ASD is associated with high
rates of psychiatric comorbidity. Most frequently, patients
suffer from comorbid depression, anxiety disorder, obsessive-
compulsive disorder and psychotic disorders. It is also closely
linked to other neurodevelopmental diseases, such as attention
deficit hyperactivity disorder (ADHD) and tic disorders (Lai
et al., 2014). Moreover, ASD is associated with epilepsy (see next
section; Lai et al., 2014). The clinical assessment for ASD involves
personal and developmental history (interviews of parents or
caregivers), behavioral observations, a physical examination
and psychometric testing as well as optional neuropsychological
tests, structured interviews, or observational measures. In
many clinical centers, instrument-based diagnostics, including
laboratory measurements, electroencephalography (EEG) and
cerebral magnetic resonance imaging (cMRI) are also performed
during clinical assessments for ASD (Tebartz van Elst, 2013).
From a pathophysiological perspective, primary forms of ASD
without a recognizable cause and secondary forms with a
recognizable cause can be distinguished. Patients with primary
forms often display a familial liability to autism however without
a well-recognized genetic disorder or syndrome. In such cases,
hereditary ASD is interpreted as a polygenetic phenomenon.
Secondary forms may be triggered by mono- or oligogenetic
disorders (e.g., fragile X syndrome, tuberous sclerosis, etc.)
or syndromes (e.g., isodicentric chromosome 15, DiGeorge
syndrome, etc.), or they may be acquired via brain disorders (e.g.,
encephalitis with epilepsy, traumatic brain injury; Tebartz van
Elst, 2013; Tebartz van Elst et al., 2013). Specific psychotherapy
programs were developed to improve social interaction among
ASD patients (e.g., The Freiburg Asperger Specific Therapy
Manual for Adult Patients or the FASTER program; Ebert et al.,
2013). So far no specific psychotropic drugs are approved for
treatment of the autistic core symptoms, but pharmacological
treatment of comorbidities or specific symptoms may be useful.
For example, patients with comorbid depression can be treated
with antidepressants, and in patients with EEG alterations,
aggressiveness and impulsivity psychotropic anticonvulsants
such as carbamazepine may be useful; however, further research
regarding treatment of ASD symptoms is needed (Tebartz van
Elst, 2013; Tebartz van Elst et al., 2013; Hirota et al., 2014).
Autism Spectrum Disorders and Epilepsy
The link between autism and epilepsy or EEG alterations is well
known. In fact, several reviews explaining this connection were
published in the last few years (Spence and Schneider, 2009; Berg
and Plioplys, 2012; Ghacibeh and Fields, 2015; Lee et al., 2015).
Epilepsy rates range from 5% to 46% in autistic patients (Spence
and Schneider, 2009; Ghacibeh and Fields, 2015), and epilepsy
was found to be associated with low IQ in many studies (e.g.,
Tuchman et al., 1991; Hara, 2007; Amiet et al., 2008; Spence
and Schneider, 2009; Berg and Plioplys, 2012). Generalized tonic-
clonic and complex partial seizures as well as absences were
described (Spence and Schneider, 2009). In addition, one-third
of childhood epilepsy cohorts fulfilled the psychometric criteria
for ASD (Clarke et al., 2005). In ASD patients without epilepsy,
increased rates of EEG pathologies ranging from 6.7% to 61%
were reported (Ghacibeh and Fields, 2015). In groups of patients
with ASD, epileptiform activity was detected in about 60% of
children (Chez et al., 2006; Kim et al., 2006) and more rarely in
adults (18% in Hara, 2007).
Role of Intermittent Rhythmic Delta
Activity (IRDA)
In this study, we investigated intermittent rhythmic delta and
theta activity (IRDA/IRTA). IRDA was first described by Cobb
(1945) and involves pathological EEG patterns with unclear
significance (Brigo, 2011). Structural, metabolic, inflammatory,
or epileptic reasons can cause theta activity (Cobb, 1945; Accolla
et al., 2011; Brigo, 2011; van Vliet et al., 2012). Structurally,
the delta rhythm might be generated in the thalamus or basal
nuclei (Cobb, 1945). We earlier hypothesized that IRDA/IRTA
can induce adaptive homeostatic processes, which could lead to
functional alternations in neuronal networks (Tebartz van Elst
et al., 2011, 2016a; Tebartz van Elst and Perlov, 2013; Endres
et al., 2016).
Rationale of Our Study
Given this theoretical background, the aim of our study was
to compare IRDA/IRTA rates between primary ASD patients
without epilepsy andmatched controls. To create a homogeneous
study cohort, only high-functioning patients with ASD were
included. We hypothesized that we would find: (1) increased
IRDA/IRTA rates in the resting EEGs of ASD patients; and
(2) a significantly more pronounced increase in IRDA/IRDA
after hyperventilation (HV) as a correlate for unstable cerebral
networks in ASD patients.
PARTICIPANTS AND METHODS
All patients and controls agreed to EEG examinations. EEG
measurements were part of the routine clinical procedure for
ASD patients. In the study, we included all available datasets
from ASD patients of the Department of Psychiatry and
Psychotherapy, University Medical Center Freiburg, between
2006 and 2012. The study was approved by the local ethics
committee (Faculty of Medicine, Freiburg University, EK-Fr
233/14) and conformed to the principles of the Declaration of
Helsinki. Control subjects were recruited from an earlier research
project (Tebartz van Elst et al., 2014; van Elst et al., 2014; Endres
et al., 2015; Maier et al., 2016).
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Patient Assessment
Only patients fulfilling the ICD-10 criteria for Asperger
syndrome were included1. The diagnostic procedure was
conducted by experienced senior consultant psychiatrists. All
clinical information about comorbidity and somatic diseases was
received from medical reports. We excluded all secondary ASD
forms to create a homogeneous study sample. Psychometric
measurements included the autism spectrum quotient (AQ;
Baron-Cohen et al., 2001) and the empathy quotient (EQ;
Baron-Cohen and Wheelwright, 2004) for autistic symptoms.
In uncertain cases, the Autism Diagnostic Interview-Revised
(Lord et al., 1994), the autism diagnostic observation schedule-
generic (Lord et al., 2000), or behavioral observations were
performed. For retrospective detection of ADHD symptoms in
childhood, the Wender Utah Rating Scale (WURS-k) was used
(Retz-Junginger et al., 2002).
Control Group
Control subjects were recruited from an earlier project (Tebartz
van Elst et al., 2014; van Elst et al., 2014; Endres et al., 2015; Maier
et al., 2016). Therefore, the control group was well investigated
using cMRIs; interviews to obtain patients’ demographics,
psychosocial characteristics andmedical histories; psychometrics
(i.e., multiple-choice vocabulary intelligence test (MWT-B;
Lehrl et al., 1995); WURS-k (Retz-Junginger et al., 2002),
AQ (Baron-Cohen et al., 2001), and EQ scores (Baron-
Cohen and Wheelwright, 2004); and semi-structured interviews
(i.e., Mini International Neuropsychiatric Interview; Sheehan
et al., 1998). Only controls without psychotropic medication,
without neurological disorders, normal intelligence, no current
axis I or II disorders, WURS-k scores of <30, and AQ scores
of<30 were included.
Matching Procedure
Between 2006 and 2012, we investigated 32 patients with ASD
(20 males, 12 females). The control group included 34 healthy
controls; one EEG was excluded due to technical reasons, one
EEG was excluded due to incomplete psychometrics. To exclude
age and gender effects, we automatically matched both variables.
This resulted in 19 well-matched patient–control pairs (9 male
pairs, 10 female pairs).
EEG Acquisition
Topographical EEG was recorded using all 21 standard locations
of the international 10–20 system (Klem et al., 1999). The
recording reference was Fpz, ground Oz. Analog signals were
recorded with a time constant of 0.3 s and a low pass of
70 Hz, sampled at 256 Hz and continuously stored for further
processing. Off-line, the digital signals were filtered between
0.3 Hz and 45 Hz and downsampled to 100 Hz. EEG monitoring
was performed for 11 min, and EEG recording was divided into
three parts: first, a resting state was maintained for 6 min; second,
a HV period was maintained for 3 min; and third, a post-HV
1http://www.who.int/classifications/icd/en/GRNBOOK.pdf
period was maintained for 2 min. NEUROFILE software was
used to register data2.
EEG Analysis
The data analysis was performed using in-house software,
avg_q3. The main steps were: (1) marking artifacts, including
signal jumps and ‘‘blocking’’, i.e., sections without signal
variation in any channel; (2) independent component analysis
(ICA) on the artifact-free data sections avoiding 5 s before
and after any artifact marker (extended ICA; Lee et al.,
1999; Makeig et al., 1999); (3) detection and correction of
electrooculographic (EOG) artifacts by exclusion of EOG-related
ICA components; and (4) detection of IRDA/IRTA. Empirically
determined thresholds were used for the detection of phase
and jump artifacts, optimizing detection and minimizing false
positive findings. IRDA/IRTA was detected in any non-excluded
independent component irrespective of topography. IRDA/IRTA
detection was achieved by filtering the activation time series of
all non-excluded independent components between 2 Hz and
7 Hz and thresholding for maximal amplitude between 25 µV
and 245µV.Only IRDA/IRTA candidates within the artifact-free
EEG sections were considered. IRDA/IRTA rates were computed
as events per minute separately for the intervals before and
after HV.
Statistical Analyses
For statistical analyses, we used Statistical Package for the
Social Sciences, version 22 (SPSS 224) and R, version 3.2.25.
The continuous variables of age, and psychometric scores
were compared using two-sided independent sample t-tests.
The gender ratio was calculated using Pearson’s two-sided
chi-square test. IRDA/IRTA rates were corrected for age,
using a linear model to estimate the predicted influence
of subjects’ age on IRDA/IRTA rates. These estimates were
then subtracted from the individual IRDA/IRTA rates. Group
comparisons for the target variables (IRDA/IRTA before HV,
IRDA/IRTA after HV, and difference in IRDA/IRTA from
before HV to after HV [abbreviated as HV difference]) were
performed using a Wilcoxon rank sum test (for inter-group
comparisons). Moreover a parametric robust (non-parametric)
repeated measures ANOVA (regular ranks) was performed
using the npIntFactRep package in R to analyze the interaction
between group and HV. We chose the robust repeated
measure ANOVA since the assumption of homogeneity of
variance was violated. In addition, medicated and unmedicated
patients were compared using a Wilcoxon rank sum test.
For outlier detection we performed a Tukey’s test. For
correlation analyses of age corrected IRDA/IRTA rates with
AQ und EQ scores, we calculated Spearman’s rank correlation.
P < 0.05 served as the criterion of significance for all statistical
analyses.
2www.neurolite.ch/?q=en/products/eeg/coherence-software
3https://github.com/berndf/avg_q
4www-01.ibm.com/software/analytics/spss
5www.r-project.org
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RESULTS
Demographic and Psychometric Data
ASD patients and controls were matched in age and gender.
In the patient group, 42% were medicated, mostly with
antidepressants (37%). As expected psychometric autistic and
ADHD scores were significantly increased in ASD patients
(Table 1).
EEG Findings
No significant difference was found between ASD patients
and control subjects regarding the rate of IRDA/IRTA before
(W = 201, r = −0.175, p = 0.564) and after HV (W = 229,
r = −0.283, p = 0.163). However, significantly increased HV
difference was detected in the ASD group (W = 248, r = −0.364,
p = 0.0497; Table 2). The comparison between medicated and
unmedicated patients showed no differences in the frequency of
IRDA/IRTA before (W = 42, r = −0.0277, p = 0.9039), after HV
(W = 53, r =−0.1576, p = 0.492), and for HV difference (W = 52,
r = −0.1389, p = 0.5448). In the robust ANOVA the interaction
group by HV was significant (F(1,36) = 6.50, p = 0.015). Outlier
detection led to the exclusion of one ASD value for before, after
and HV difference. The Wilcoxon test remained significant for
the HV difference (W = 229, r = −0.3372, p = 0.0403) and not
significant for IRDA/IRTA rates before (W = 182, r = −0.1455
p = 0.3763) and after HV (W = 210, r =−0.2538, p = 0.1226).
Analysis of Dimensional Associations
The correlation analysis in the ASD group showed no significant
correlations between IRDA/IRTA and autism scores (AQ, EQ).
DISCUSSION
The main finding of our study is the significantly increased
HV difference in primary non-syndromal ASD patients.
Contradictory to our hypothesis, we found no significant
difference between the ASD and control groups in
terms of the IRDA/IRTA rate in resting EEGs. Still the
IRDA/IRTA-HV- difference might turn out to be a marker of
discrete but possible relevant neuronal network instability.
Comparison to Previous Studies
To our knowledge, this is the first study analyzing IRDA/IRTA
in ASD patients. Our findings (significant increase in HV
difference) are in line with earlier reports of increased rates
of EEG alterations for children and adults with autism.
In most previous studies, there was no differentiation
between EEG alterations before and after HV. However,
the absence of EEG alterations before HV is contrary to
most findings (Spence and Schneider, 2009; Ghacibeh and
Fields, 2015). The most likely explanation for this is the fact
that we concentrated on high-functioning non-secondary
autism in adults while most other previous studies did
not differentiate between secondary and primary autism.
Therefore other study groups contained also secondary and
syndromal autism which is known to be more closely linked to
epilepsy.
Furthermore most studies have focused on children, mostly
with mental retardation (see overviews from Kawasaki et al.,
1997; Spence and Schneider, 2009; Ghacibeh and Fields,
2015). Although some studies included adult patients with
autism (e.g., Tuchman et al., 1991; Kawasaki et al., 1997;
Giovanardi Rossi et al., 2000; Hughes and Melyn, 2005;
Chez et al., 2006; Hartley-McAndrew and Weinstock, 2010),
studies focusing only on adult cohorts are rare. Hara observed
130 patients with autistic disorder or atypical autism. In
adulthood (18–35 years), 25% exhibited epileptic seizures; 68%
of the epileptic group revealed epileptiform EEG findings
before onset of epilepsy, 18% of the non-epileptic group
exhibited epileptic discharges, and lower IQs were observed
in the epileptic group (Hara, 2007). To our knowledge, no
studies have analyzed high-functioning cohorts, as we did.
EEG alterations in autism research might be influenced by
different evaluation methods and the inclusion of different
ASD subgroups (see ‘‘Discussion’’ Section about the nosology
problem). For evaluation methods, we used routine EEGs.
Earlier studies analyzing short routine EEGs found lower
TABLE 1 | Demographic and psychometric information for the ASD and control groups.
ASD (n = 19) mean ± SD/n Controls (n = 19) mean ± SD/n Statistics
Age 38.37 ± 9.429 37.79 ± 8.331 p = 0.842
Gender 9 male: 10 female 9 male: 10 female p = 1.0
Psychotropic drugs None: 11 (58%) None
Yes: 8 (42%)
- Antidepressants in 7/19 [37%]
- MPH in 2/19 [11%]
- Mood-stabilizer (lamotrigine): 1/19 [5%]
- Tranquillizer (zolpidem): 1/19 [5%]
- Atypical neuroleptics (promethazine): 1/19 [5%]
AQ 38.00 ± 7.446 12.58 ± 4.959 p < 0.001
EQ 17.68 ± 9.363 44.63 ± 14.280 p < 0.001
WURS-k 26.42 ± 17.270 5.26 ± 5.536 p < 0.001
Abbreviations: ASD, autism spectrum disorder; SD, standard deviation; IQ, intelligence quotient; M, male; F, female; MPH, methylphenidate; AQ, autism-spectrum quotient;
EQ, empathy quotient; WURS-k, Wender Utah Rating Scale.
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TABLE 2 | IRDA/IRTA per min in the ASD group and the control group.
ASD (n = 19) mean ± SD Controls (n = 19) mean ± SD Statistics Wilcoxon
IRDA/IRTA per min before HV 1.155 ± 1.452 0.793 ± 0.841 W = 201
r = −0.175
p = 0.564
IRDA/IRTA per min after HV 3.594 ± 5.528 1.038 ± 1.303 W = 229
r = −0.283
p = 0.163
Difference between IRDA/IRTA per min after HV and before HV 2.439 ± 4.987 0.245 ± 1.052 W = 248
r = −0.364
p = 0.0497
Abbreviations: ASD, autism spectrum disorder; HV, hyperventilation; IRDA, intermittent rhythmic delta activity; IRTA, intermittent rhythmic theta activity. Significant p-values
are written in bold.
rates of EEG alterations (Hara, 2007). In contrast, high rates
of EEG alterations were found with video EEG monitoring
(epileptiform abnormalities in 59%; Kim et al., 2006) or 24 h
digital overnight EEGs (epileptiform abnormalities in 61%; Chez
et al., 2006).
The Nosology Problem
If we look at previous EEG studies on autism, the nosology
problem i.e., the fact that ASD comprises patient subgroups
with diverse pathophysiologies, becomes apparent (Tebartz van
Elst et al., 2006, 2013, 2014; Endres et al., 2015). Different
subgroups of ASD can be distinguished by age, gender,
course of disease, level of functioning, etiological variables
and comorbidity. Regarding age, children, adolescent and
adult patients must be distinguished; the dynamic changes in
the brain during childhood and adolescence might result in
different electrophysiological properties. In the current study,
we investigated only adult patients and compared them with
age-matched control subjects; therefore, developmental changes
should be of no consequence. Regarding gender, earlier research
reported increased prevalence of EEG alterations in young
females on a meta-analytic-level (Amiet et al., 2008). In this
study, we compared gender-matched ASD and control groups
to exclude gender effects. Regarding the course of the disease,
patients with early infantile autism, atypical autism, or Asperger
syndrome must be distinguished. Developmental regression,
which is observed in one-third of children with autism (Kawasaki
et al., 1997), has been found to be associated with EEG alterations
(Ghacibeh and Fields, 2015). EEG alterations were frequent in
patients with regressive autism, and epileptiform activity was
found more often in patients with regression than in patients
without regression (Tuchman and Rapin, 1997; Lewine et al.,
1999; Shinnar et al., 2001). However, other studies found no
such differences in patients with developmental regression (Rossi
et al., 1995; Chez et al., 2006; Giannotti et al., 2008). Regarding
the level of functioning, high-functioning patients with normal
or above-average IQs and effective use of language should
be distinguished from low-functioning patients with low IQs
and no communicative language. In support of this distinction
a meta-analysis reported a higher prevalence of epilepsy in
patients with intellectual disability (21.5%) compared to patients
without intellectual disability (8%; Amiet et al., 2008). Regarding
etiological variants, primary idiopathic forms of ASD must be
distinguished from secondary non-idiopathic forms caused by
acquired brain disorders, genetic disorders, or syndromal autism
(Tebartz van Elst, 2013; Tebartz van Elst et al., 2013). Patients
with secondary non-idiopathic forms were affected by epilepsy
more often than patients suffering from primary idiopathic
forms (Pavone et al., 2004; Miles et al., 2005). Finally, patients
must be distinguished by comorbidity. Frequent developmental
comorbidities are ADHD and tic disorders, and epilepsy itself
is also an important neurological comorbid disorder (Lai
et al., 2014). It can be assumed that EEG alterations are
more prevalent in ASD patients with comorbid epilepsy (Hara,
2007). Until now, most studies have analyzed low-functioning
children and adolescents (i.e., the typical patients of child
and adolescent psychiatrists). To create a homogeneous study
group and exclude developmental influences, we focused on
high-functioning adults with primary variants and without
relevant somatic comorbidities (particularly epilepsy but also a
history of relevant birth complications or inflammatory brain
disease). Such patients might suffer from a less severe form
of ASD. In line with that idea, epileptiform activity was less
common in patients with Asperger syndrome than in patients
with more severe forms of autism (Mulligan and Trauner,
2014).
In summary, it can be noted that ASD is a heterogeneous
disorder comprising many etiological subgroups and underlying
pathophysiologies. The fact that we found no difference in the
IRDA/IRTA rate before HV between groups might be explained
by our inclusion of less severe forms of ASD without intellectual
disability or developmental regression.
Electrophysiological Perspective: The
Cybernetic Role of Hyperventilation
In our study, the HV difference was significantly different.
Therefore, the question of the role of HV arises. HV is
an effective provocation method leading to decreased blood
carbon dioxide levels, and therefore to cerebral vasoconstriction
(Barker et al., 2012). This might result in EEG changes, such
as physiological slowing, IRDA/IRTA, or epileptiform activity
(Siddiqui et al., 2011; Barker et al., 2012). Interictal epileptiform
activity was found particularly in patients with generalized
epilepsy, but also in patients with focal epilepsy (Ahdab and
Riachi, 2014; Kane et al., 2014). The role of EEG changes
in patients without epileptic seizures is still unresolved. The
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phenomenon of HV-induced high-amplitude rhythmic slow
activity with altered awareness in children without epilepsy
was described as an epileptiform occurrence and physiological
process (Barker et al., 2012). In this study, we focused on
automatic detection of IRDA/IRTA, which is clearly pathological
excitatory neuronal network activity (Tebartz van Elst et al.,
2016a).
Clinical View: The Effects of IRDA/IRTA
and Network Inhibition
The most important clinical question is whether there is a
causal relationship between EEG alterations and ASD symptoms.
We hypothesize that local area network inhibition could
cause short-term effects and epileptic encephalopathy could
cause long-term effects. Alternatively, EEG alterations might
simply be an epiphenomenon of a pathophysiological process
responsible for ASD (Spence and Schneider, 2009).
Short-Term Effects: Local Area Network Inhibition
As described above, IRDA/IRTA is a pathological excitatory
neuronal network activity. If such primary excitatory activity
is focal and frequent enough, it could trigger a secondary
homoeostatic reaction to which we have referred in previous
publication using the term local area neuronal network
inhibition (LANI). These putative inhibitory processes are
conceptualized as a cybernetic homoeostatic mechanism of
the brain to keep the functional equilibrium of the local
neuronal network. While discrete and distributed LANI
might not present with any clinical symptoms, ongoing
suprathreshold LANI could in fact cause such symptoms. The
nature of such phenomena then depends on the location
of inhibited brain regions or anatomical loops (Tebartz
van Elst et al., 2011; Tebartz van Elst and Perlov, 2013).
Ongoing LANI in the frontal lobe might lead to stimulus
satiation, and LANI in the left temporal lobe might trigger
hallucinations.
Long-Term Effects: Epileptic Encephalopathy
Neuronal network instability as represented by IRDA/IRTA
activity may lead to short term LANI effects illustrated
above. But it may also cause long term effects stimulating
the brain to restructure itself into a connectivistic pattern
that minimizes the spread of epileptic activity (Tebartz
van Elst et al., 2016b). Frequent epileptiform patterns can
also interfere with normal neuronal physiology and brain
development, disrupting various neurocognitive processes
(i.e., plasticity, memory encoding and language processing)
and causing developmental delays, regression or disruption.
While this notion is controversial, respective results have
been observed for other established syndromes (Holmes and
Lenck-Santini, 2006; Ghacibeh and Fields, 2015). For instance,
the Landau–Kleffner syndrome is characterized by language
regression in normally developing children and is associated
with EEG alterations mainly during sleep (Tebartz van Elst
and Perlov, 2013). Cognitive functioning in patients with
epileptic encephalopathy improves following normalization
of their EEGs (Holmes and Lenck-Santini, 2006). Studies
on children showed that antiepileptic treatment of interictal
epileptiform activity could improve psychosocial function
(Binnie, 2003; García-Peñas, 2011). On the background of
such observations the question arises if the IRDA/IRTA-
HV difference might serve as a biomarker indicating
FIGURE 1 | Frequency of IRDA/IRTA events before and after HV in the ASD and control groups. Presented are medians with upper and lower quantiles of
corrected IRDA/IRDA rates. The use of age-corrected IRDA/IRTA-rates could result in negative corrected densities (i.e., IRDA/IRTA rates < 0). The red dots show the
means. Abbreviations: ASD, autism spectrum disorder; HV, hyperventilation; IRDA, intermittent rhythmic delta activity; IRTA, intermittent rhythmic theta activity;
NTC, neurotypical controls.
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pathophysiological relevant neuronal network instability in
a given patient.
Limitations
Study Cohort
The study was retrospective; we included only patients from
our clinic with ASD that were diagnosed between 2006 and
2012. To create a homogeneous study group, we included
only adult patients with primary high-functioning forms of
ASD. Patients with comorbid epilepsy and atypical autism
were excluded from the study. In our previous studies on
ASD, we established study cohorts with normal or above-
average IQs as a filter for primary forms of ASD (Riedel
et al., 2014; Tebartz van Elst et al., 2014). In the current
study, IQ values were not available from all patients. To
exclude secondary forms of ASD, the available clinical
information was checked precisely. Additionally, we included
medicated and unmedicated patients, which might have
influenced our results. However, the IRDA/IRTA rates
in medicated and unmedicated patients did not differ in
statistical comparisons. Moreover, the total sample size
could have been larger than 38, and further studies with
increased numbers of subjects should be performed to
confirm our findings. To subtract the possible variance of
age and gender, we performed pairwise matching for these
variables, which created highly comparable patient and control
groups.
EEG Measurements and Statistical Analyses
We assessed routine 11-min EEG studies. Repeated EEG
recordings, sleep and sleep deprivation measurements, or video
EEG telemetry probably would have led to higher rates of
EEG alteration. Therefore, our findings should be regarded
as representing the minimum detection rate in this sample.
The data analysis was performed completely automatically and
independent of an investigator. Thus we can exclude elements
of rating bias. The method is published on the Internet
and is therefore accessible to the reader. Regarding statistical
analyses, there is potential to criticize our inclusion of outliers
(Figure 1). However, we believe that these outliers could present
the subgroup of subjects with network instability. In these
patients (and in all the other patients), no secondary explanation
(e.g., epilepsy or brain disease) of the IRDA/IRTA rates was
found. The inclusion of these subjects in the statistical calculation
resulted in a non-normal distribution of the IRDA/IRTA rates,
which was considered in the statistics through the application
of a Wilcoxon rank sum test. However, even with using
outlier detection, the results remained significant for the HV
difference.
CONCLUSION
The primary finding of our study is a significantly increased HV
difference in non-syndromal, high-functioning, epilepsy-free
adult ASD patients. Further studies analyzing EEG alterations in
larger cohorts of high-functioning adults with ASD are needed.
An increased rate of IRDA/IRTA might be a neurophysiological
marker of neuronal network instability which could have
etiological and predictive relevance. For example it might modify
cerebral information processing via short-term effects in terms
of LANI or long-term effects via epileptic encephalopathy.
The therapeutic implication of our findings is still unclear.
Treatment with antiepileptic medication might be effective
in such constellations. However, to prove this assumption,
further clinical research with blinded, placebo-controlled
intervention trials of ASD patients with EEG alterations are
necessary.
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